Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos
Brink's (BCO) announced the UK's CMA accepted its proposed remedy for the acquisition of NCR Atleos (NATL), involving the divestiture of NoteMachine/TestLink UK. The deal is on track to close in early Q1 2027, with $200M in expected annual cost synergies. Brink's is engaging with prospective buyers for the divestiture.
How this was made
The 30-second read
Why it matters
The CMA's acceptance in principle removes a major regulatory obstacle, likely improving deal certainty and supporting both companies' valuations.
Market read
Regulatory progress on a significant M&A transaction, relevant for investors in the security services sector and broader M&A activity.
What to watch
Potential antitrust concerns in other jurisdictions and integration execution risk.
Background
Brink's is pursuing the acquisition of NCR Atleos to expand its cash and valuables management services. The U.K. CMA required a remedy to address competition concerns.
Ticker impact
CMA accepted Brink's proposed remedy for its pending acquisition of NCR Atleos, clearing a regulatory hurdle.
potential upside as market prices in reduced regulatory risk
The acceptance removes a possible Phase 2 referral, a material uncertainty for the transaction.
Brink's acquisition of NCR Atleos remains on track after CMA acceptance of the remedy.
moderate upside as acquisition likelihood improves
Regulatory approval is a key step; investors may reprice the target higher.
Market effects
Cash handling and security services sector may see consolidation benefits.
U.K. regulatory clearance may boost confidence in other cross‑border M&A.
Highlights regulatory scrutiny in M&A, relevant for global dealmakers.
Counterpoint
If the divestiture fails, the deal could still face delays, limiting upside.
Key entities
- CompanyThe Brink's Company
U.S. cash handling and security services provider (NYSE: BCO).
- CompanyNCR Atleos Corporation
U.S. provider of cash handling solutions (NYSE: NATL).